SELECT PUBLICATIONS

Mauri D et al. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: A meta-analysis. J Natl Cancer Inst 2006;98:1285-91. Abstract

Paik S et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006;24(23):3726-34. Abstract

Paik S et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351(27):2817-26. Abstract

Paik S et al. Multi-gene RT-PCR assay for predicting recurrence in node negative breast cancer patients — NSABP studies B-20 and B-14. San Antonio Breast Cancer Symposium 2003;Abstract 16.

Winer EP et al. American Society of Clinical Oncology Technology Assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status Report 2004. J Clin Oncol 2005;23(3):619- 29. Abstract

 

 

 

 

 

 

 

 

 

 

 

 

Table of Contents

Top of Page

Home · Search

Editor:
Neil Love, MD

Interviews
Rache M Simmons, MD
- Select publications

Peter M Ravdin, MD, PhD
- Select publications

Henry M Kuerer, MD, PhD
- Select publications

Debu Tripathy, MD
- Select publications

D Lawrence Wickerham, MD
- Select publications

Richard Sainsbury, MD
- Select publications

CME Information

Faculty Disclosures

Editor's Office